Penn Medicine Teams Up with Cost Plus Drugs to Lower Medication Costs

Penn Medicine has partnered with Mark Cuban’s Cost Plus Drug Company to provide affordable generic medications through its retail pharmacy network, improving medication access and affordability for patients. Rising prescription drug costs remain a major barrier, often causing medication non-adherence and negative health outcomes. This collaboration leverages Cost Plus Drug Company’s transparent pricing model to address this challenge.

Penn Medicine’s integrated pharmacy system supports comprehensive patient care by enhancing medication management, optimizing treatment regimens, and offering patient education and financial assistance. This ensures that medications are both effective and affordable.

“As health systems face rising costs on many fronts, we’re constantly looking for creative ways to be more cost-effective and simplify care delivery to meet the needs of our patients and care teams,” said Kevin B. Mahoney, CEO of the University of Pennsylvania Health System. “Cost Plus is a new model that will eliminate unnecessary mark-ups on common generic medications and allow us to reinvest those savings in care innovations that are giving patients new choices and setting new standards for medicine.”